SG11201607086QA - Novel methods for inducing an immune response - Google Patents

Novel methods for inducing an immune response

Info

Publication number: SG11201607086QA
Authority: SG; Singapore
Prior art keywords: inducing; immune response; novel methods; novel; methods
Prior art date: 2014-04-02

Application number

SG11201607086QA

Other languages

English (en)

Inventor

William Ripley Ballou Jr

Arnaud Michel Didierlaurent

Der Most Robbert Gerrit Van

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-04-02

Filing date

2015-04-02

Publication date

2016-09-29

2015-04-02 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2016-09-29 Publication of SG11201607086QA publication Critical patent/SG11201607086QA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SG11201607086QA 2014-04-02 2015-04-02 Novel methods for inducing an immune response SG11201607086QA (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB1405921.6A GB201405921D0 (en)	2014-04-02	2014-04-02	Novel methods for inducing an immune response
PCT/EP2015/057424 WO2015150568A1 (fr)	2014-04-02	2015-04-02	Nouveaux procédés d'induction d'une réponse immunitaire

Publications (1)

Publication Number	Publication Date
SG11201607086QA true SG11201607086QA (en)	2016-09-29

Family

ID=50737873

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG11201607086QA SG11201607086QA (en)	2014-04-02	2015-04-02	Novel methods for inducing an immune response

Country Status (18)

Country	Link
US (3)	US10688168B2 (fr)
EP (2)	EP3125930B1 (fr)
JP (2)	JP6645982B2 (fr)
KR (2)	KR20160132115A (fr)
CN (2)	CN106456739A (fr)
AR (1)	AR099960A1 (fr)
AU (1)	AU2015239025B2 (fr)
BE (1)	BE1022355B1 (fr)
BR (2)	BR112016022787A2 (fr)
CA (2)	CA2943007C (fr)
EA (1)	EA037405B1 (fr)
ES (2)	ES2961840T3 (fr)
GB (1)	GB201405921D0 (fr)
IL (1)	IL247493B (fr)
MX (3)	MX2016012982A (fr)
SG (1)	SG11201607086QA (fr)
WO (2)	WO2015150567A1 (fr)
ZA (1)	ZA201605955B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201405921D0 (en) *	2014-04-02	2014-05-14	Glaxosmithkline Biolog Sa	Novel methods for inducing an immune response
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
US12016919B2 (en)	2017-05-30	2024-06-25	Glaxosmithkline Biologicals Sa	Methods for manufacturing an adjuvant
CA3083078A1 (fr)	2017-12-01	2019-06-06	Glaxosmithkline Biologicals Sa	Purification de saponine
BR112021024363A2 (pt)	2019-06-05	2022-03-22	Glaxosmithkline Biologicals Sa	Purificação de saponina
CN112198318B (zh) *	2020-07-15	2021-07-20	南京岚煜生物科技有限公司	抗体标准品赋值和抗体检测试剂最低检出限确定的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US152200A (en) *		1874-06-16		Improvement in garters
US1002607A (en) *	1905-08-28	1911-09-05	John Willard Taylor	Paper pulley.
UA56132C2 (uk) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
RU2356577C9 (ru)	2002-10-23	2009-08-10	Глаксосмитклайн Байолоджикалс С.А.	Способы вакцинации против малярии
RS52187B (sr)	2004-10-14	2012-10-31	Crucell Holland B.V.	Vakcine za indukciju i stimulaciju imunskog odgovora za malariju
EP1877426B1 (fr) *	2005-04-29	2012-02-01	GlaxoSmithKline Biologicals SA	Méthode de prévention ou de traitement d'une infection par m tuberculosis
TWI457133B (zh) *	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
EP2087128A4 (fr) *	2006-11-01	2009-11-04	Immport Therapeutics Inc	Composition et procédés pour des antigènes immunodominants
LT2137210T (lt) *	2007-03-02	2016-12-27	Glaxosmithkline Biologicals Sa	Naujas būdas ir kompozicijos
US9452209B2 (en) *	2007-04-20	2016-09-27	Glaxosmithkline Biologicals Sa	Influenza vaccine
EP2315834B1 (fr) *	2008-07-25	2018-06-13	GlaxoSmithKline Biologicals S.A.	Protéine rv2386c tuberculosis, compositions et utilisations correspondantes
SI2315773T1 (sl) *	2008-07-25	2016-12-30	Glaxosmithkline Biologicals S.A.	Polipeptidi, polinukleotidi in sestavki za uporabo pri zdravljenju latentne tuberkuloze
NO2315597T3 (fr) *	2008-07-25	2018-01-20
US8932600B2 (en) *	2010-01-27	2015-01-13	Glaxosmithkline Biologicals S.A.	Modified tuberculosis antigens
KR20190022897A (ko) *	2010-12-14	2019-03-06	글락소스미스클라인 바이오로지칼즈 에스.에이.	미코박테리움 항원성 조성물
US20170056345A1 (en) *	2014-02-18	2017-03-02	Stc.Unm	Booster drug therapy for mycobacterium infections
GB201405921D0 (en) *	2014-04-02	2014-05-14	Glaxosmithkline Biolog Sa	Novel methods for inducing an immune response
US10004793B2 (en) *	2014-04-24	2018-06-26	Statens Serum Institut	M.tuberculosis vaccines
GB201513176D0 (en) *	2015-07-27	2015-09-09	Glaxosmithkline Biolog Sa	Novel methods for inducing an immune response

2014
- 2014-04-02 GB GBGB1405921.6A patent/GB201405921D0/en not_active Ceased
2015
- 2015-04-02 JP JP2016559965A patent/JP6645982B2/ja active Active
- 2015-04-02 EA EA201691638A patent/EA037405B1/ru not_active IP Right Cessation
- 2015-04-02 EP EP15713531.0A patent/EP3125930B1/fr active Active
- 2015-04-02 BE BE2015/5209A patent/BE1022355B1/fr not_active IP Right Cessation
- 2015-04-02 ES ES15713532T patent/ES2961840T3/es active Active
- 2015-04-02 EP EP15713532.8A patent/EP3125929B8/fr active Active
- 2015-04-02 KR KR1020167029523A patent/KR20160132115A/ko not_active Ceased
- 2015-04-02 CN CN201580030331.2A patent/CN106456739A/zh active Pending
- 2015-04-02 US US15/300,852 patent/US10688168B2/en active Active
- 2015-04-02 MX MX2016012982A patent/MX2016012982A/es unknown
- 2015-04-02 ES ES15713531T patent/ES2853773T3/es active Active
- 2015-04-02 CA CA2943007A patent/CA2943007C/fr active Active
- 2015-04-02 MX MX2016012932A patent/MX2016012932A/es unknown
- 2015-04-02 US US15/300,338 patent/US10624961B2/en active Active
- 2015-04-02 CA CA2943711A patent/CA2943711A1/fr not_active Abandoned
- 2015-04-02 CN CN201580016665.4A patent/CN106456738B/zh active Active
- 2015-04-02 AU AU2015239025A patent/AU2015239025B2/en active Active
- 2015-04-02 BR BR112016022787-5A patent/BR112016022787A2/pt not_active Application Discontinuation
- 2015-04-02 KR KR1020237017095A patent/KR102762440B1/ko active Active
- 2015-04-02 WO PCT/EP2015/057423 patent/WO2015150567A1/fr not_active Ceased
- 2015-04-02 WO PCT/EP2015/057424 patent/WO2015150568A1/fr not_active Ceased
- 2015-04-02 IL IL247493A patent/IL247493B/en unknown
- 2015-04-02 JP JP2016560336A patent/JP6655549B2/ja not_active Expired - Fee Related
- 2015-04-02 SG SG11201607086QA patent/SG11201607086QA/en unknown
- 2015-04-02 BR BR112016022463A patent/BR112016022463A2/pt not_active Application Discontinuation
- 2015-04-06 AR ARP150101025A patent/AR099960A1/es unknown
2016
- 2016-08-26 ZA ZA2016/05955A patent/ZA201605955B/en unknown
- 2016-09-30 MX MX2022013912A patent/MX2022013912A/es unknown
2020
- 2020-03-11 US US16/815,635 patent/US11951161B2/en active Active

Also Published As

Publication number	Publication date
BE1022355A1 (fr)	2016-02-16
ES2961840T3 (es)	2024-03-14
US20170112914A1 (en)	2017-04-27
CA2943711A1 (fr)	2015-10-08
US10624961B2 (en)	2020-04-21
EA201691638A1 (ru)	2017-04-28
EP3125929B8 (fr)	2023-12-27
WO2015150568A1 (fr)	2015-10-08
AU2015239025A1 (en)	2016-09-22
BR112016022463A2 (pt)	2017-10-10
WO2015150567A1 (fr)	2015-10-08
MX2022013912A (es)	2022-12-13
US20200306353A1 (en)	2020-10-01
ES2853773T3 (es)	2021-09-17
MX2016012932A (es)	2016-12-07
CA2943007A1 (fr)	2015-10-08
CA2943007C (fr)	2024-01-09
AU2015239025B2 (en)	2018-01-25
IL247493B (en)	2022-08-01
EP3125929A1 (fr)	2017-02-08
CN106456739A (zh)	2017-02-22
JP6645982B2 (ja)	2020-02-14
KR20230075525A (ko)	2023-05-31
US10688168B2 (en)	2020-06-23
JP2017511327A (ja)	2017-04-20
KR20160132115A (ko)	2016-11-16
EP3125930A1 (fr)	2017-02-08
MX2016012982A (es)	2016-12-07
KR102762440B1 (ko)	2025-02-03
EP3125929B1 (fr)	2023-11-01
IL247493A0 (en)	2016-11-30
AR099960A1 (es)	2016-08-31
ZA201605955B (en)	2019-04-24
BE1022355B1 (fr)	2016-03-26
CN106456738A (zh)	2017-02-22
JP2017511324A (ja)	2017-04-20
EP3125930B1 (fr)	2020-12-02
BR112016022787A2 (pt)	2018-03-27
JP6655549B2 (ja)	2020-02-26
CN106456738B (zh)	2021-06-29
GB201405921D0 (en)	2014-05-14
US20170136110A1 (en)	2017-05-18
US11951161B2 (en)	2024-04-09
EA037405B1 (ru)	2021-03-25
EP3125929C0 (fr)	2023-11-01

Publication	Publication Date	Title
IL257071A (en)	2018-03-29	New methods for inducing an immune response
GB201410971D0 (en)	2014-08-06	Vaccine
GB201410262D0 (en)	2014-07-23	Novel method
GB201413086D0 (en)	2014-09-03	Methods
GB201621686D0 (en)	2017-02-01	Novel methods for inducing an immune response
GB201404996D0 (en)	2014-05-07	Apparatus
GB2526680B (en)	2021-05-19	Runway arrangement
ZA201605955B (en)	2019-04-24	Novel methods for inducing an immune response
GB201420047D0 (en)	2014-12-24	Force-measuring apparatus
SG11201703801SA (en)	2017-06-29	Novel methods
GB201409933D0 (en)	2014-07-16	Novel device
GB201408745D0 (en)	2014-07-02	Methods
GB201703042D0 (en)	2017-04-12	Mechanical apparatus
PL3169830T3 (pl)	2020-11-02	Urządzenie do elektrochlorowania
GB201402233D0 (en)	2014-03-26	Apparatus
GB201416773D0 (en)	2014-11-05	Novel Methods For Including An Imune Response
HUE053284T2 (hu)	2021-06-28	Vakcina
GB201415685D0 (en)	2014-10-22	Methods
GB201417214D0 (en)	2014-11-12	Vaccine
GB201405509D0 (en)	2014-05-14	Novel Device
GB201406628D0 (en)	2014-05-28	Vaccine
GB2524070B (en)	2017-07-12	Suspension device
GB201401565D0 (en)	2014-03-19	Novel method
GB201417040D0 (en)	2014-11-12	Novel device
GB201414122D0 (en)	2014-09-24	Methods